Suppr超能文献

改良的临床免疫表型分析面板:紫激光的应用。

Improved panels for clinical immune phenotyping: Utilization of the violet laser.

机构信息

Amerimmune LLC, Fairfax, Virginia.

Department of Pathology, SUNY, New York.

出版信息

Cytometry B Clin Cytom. 2018 Sep;94(5):671-679. doi: 10.1002/cyto.b.21532. Epub 2017 May 22.

Abstract

BACKGROUND

Clinical diagnostic laboratories are subject to numerous regulations imposed by government agencies. Laboratory developed tests for flow cytometry panels are essentially restricted to the use of analyte-specific reagents (ASR) antibodies. With the advances in clinical flow cytometry systems, there is a trend toward the utilization of blue/red/violet laser flow systems and 8 to 10-color panels. Currently, the selection of commercially available ASR antibodies for the violet laser is very limited. The market is dominated by Brilliant Violet 421 (BV421) manufactured by BD Biosciences and Pacific Blue (PB) manufactured by Beckman Coulter. In this study, we compare BV421 and PB conjugated ASR antibodies.

METHODS

Whole blood was stained and acquired on a Gallios flow cytometer system. For single color staining, the stain index (SI) was calculated. For the two panels, the compensation matrix was calculated and the performance of the antibody cocktails analyzed in FCS Express.

RESULTS

The results show that five out of six tested BV421 conjugated antibodies have significantly higher SI than their PB counterparts. Furthermore, BV421 antibodies require less compensation for spillover than PB. Finally, BV421 conjugated antibodies give better separation between negative and positive populations in the context of an 8 and 10 color panel without affecting the intensity of the other dyes.

CONCLUSIONS

Overall, using BV421 conjugated antibodies results in better separation between populations compared to PB conjugated antibodies without negatively affecting other fluorochromes in our panels. We conclude that the BV421 conjugated ASR antibodies are currently the better available option for clinical flow panels. © 2017 International Clinical Cytometry Society.

摘要

背景

临床诊断实验室受到政府机构实施的众多法规的约束。用于流式细胞仪检测试剂盒的实验室开发检测主要限于使用分析物特异性试剂 (ASR) 抗体。随着临床流式细胞仪系统的进步,越来越倾向于使用蓝/红/紫激光流式系统和 8 到 10 色检测试剂盒。目前,用于紫激光的商业上可用的 ASR 抗体选择非常有限。市场主要由 BD Biosciences 生产的 Brilliant Violet 421 (BV421) 和 Beckman Coulter 生产的 Pacific Blue (PB) 主导。在这项研究中,我们比较了 BV421 和 PB 偶联的 ASR 抗体。

方法

使用 Gallios 流式细胞仪系统对全血进行染色和采集。对于单染,计算染色指数 (SI)。对于两个试剂盒,计算补偿矩阵,并在 FCS Express 中分析抗体混合物的性能。

结果

结果表明,六种测试的 BV421 偶联抗体中有五种的 SI 明显高于其 PB 对应物。此外,BV421 抗体的溢出补偿要求低于 PB。最后,在 8 色和 10 色检测试剂盒中,BV421 偶联抗体在不影响其他染料强度的情况下,能够更好地区分阴性和阳性群体。

结论

总的来说,与 PB 偶联抗体相比,使用 BV421 偶联抗体可更好地区分群体,而不会对我们的试剂盒中的其他荧光染料产生负面影响。我们得出结论,BV421 偶联的 ASR 抗体是目前临床流式检测试剂盒的更好选择。© 2017 年国际临床细胞学会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验